Neuro-Oncology Reviews
Volume
25 Number 3
15 February 2023
Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 3, 15 February
Jordan JT,
Gerstner ER.
Imaging
of Brain Tumors.
Continuum
(Minneap Minn). 2023 Feb 1;29(1):171-193∟.
doi: 10.1212/CON.0000000000001202∟.
PMID: 36795877∟.
Review˰ ˍ
Gerardi RM,
Cannella R, Bonosi L, Vernuccio F, Ferini G, Viola A, Zagardo V,
Buscemi F, Costanzo R, Porzio M, Giovannini EA, Paolini F,
Brunasso L, Giammalva GR, Umana GE, Scarpitta A, Iacopino DG,
Maugeri R.
Forecasting
Molecular Features in IDH-Wildtype Gliomas: The State of the Art
of Radiomics Applied to Neurosurgery.
Cancers
(Basel). 2023 Feb 2;15(3):940∟.
doi: 10.3390/cancers15030940∟.
PMID: 36765898∟.
Review. ˍ
Hosseinalizadeh
H, Ebrahimi A, Tavakoli A, Monavari SH.
Glioblastoma
as a novel drug repositioning target: Updated state.
Anticancer
Agents Med Chem. 2023 Feb 2∟.
doi: 10.2174/1871520623666230202163112∟.
PMID: 36733195∟.
Review˰ ˍ
Jia JL,
Alshamsan B, Ng TL.
Temozolomide
Chronotherapy in Glioma: A Systematic Review.
Curr
Oncol. 2023 Feb 4;30(2):1893-1902∟.
doi: 10.3390/curroncol30020147∟.
PMID: 36826108∟.
Review. ˍ
Mirchia K, Mahoney MT, Christie O, Fuller CE, Mirchia K.
A
Rare Tumor in a Rare Location: Radiology and Pathology Findings
With a Literature Review on Intraventricular Gliosarcoma.
Cureus.
2023 Feb 4;15(2):e34622∟.
doi: 10.7759/cureus.34622∟.
PMID: 36891012∟.
Case report, Review. ˍ
Wong SC,
Kamarudin MNA, Naidu R.
Anticancer
Mechanism of Flavonoids on High-Grade Adult-Type Diffuse
Gliomas.
Nutrients.
2023 Feb 4;15(4):797∟.
doi: 10.3390/nu15040797∟.
PMID: 36839156∟.
Review. ˍ
Kotch C,
Brosius SN, De Raedt T, Fisher MJ.
Updates
in the Management of Central and Peripheral Nervous System Tumors
among Patients with Neurofibromatosis Type 1 and Neurofibromatosis
Type 2.
Pediatr
Neurosurg. 2023 Feb 6∟.
doi: 10.1159/000529507∟.
PMID: 36746138∟.
Review. ˍ
Rechberger JS, Power BT, Power EA,
Nesvick CL, Daniels DJ.
H3K27-altered
diffuse midline glioma: A paradigm shifting opportunity in direct
delivery of targeted therapeutics.
Expert
Opin Ther Targets. 2023 Feb 6∟.
doi: 10.1080/14728222.2023.2177531∟.
PMID: 36744399∟.
Review˰ ˍ
Young S, Phaterpekar K, Tsang DS, Boldt G, Bauman GS.
Proton
Radiotherapy for Management of Medulloblastoma: A Systematic
Review of Clinical Outcomes.
Adv
Radiat Oncol. 2023 Feb 7;8(4):101189∟.
doi: 10.1016/j.adro.2023.101189∟.
PMID: 37008255∟.
Review.
ˍ
Eibl RH,
Schneemann M.
Medulloblastoma:
From TP53 Mutations to Molecular Classification and Liquid
Biopsy.
Biology
(Basel). 2023 Feb 8;12(2):267∟.
doi: 10.3390/biology12020267∟.
PMID: 36829544∟.
Review. ˍ
Wang Y, Liu
R, Zhang Q, Dong M, Wang D, Chen J, Ou Y, Luo H, Yang K, Wang
X.
Charged
particle therapy for high-grade gliomas in adults: a systematic
review.
Radiat
Oncol. 2023 Feb 8;18(1):29∟.
doi: 10.1186/s13014-022-02187-z∟.
PMID: 36755321∟.
Review. ˍ
Crainic N,
Furtner J, Pallud J, Bielle F, Lombardi G, Rudà R, Idbaih
A.
Rare
Neuronal, Glial and Glioneuronal Tumours in Adults.
Cancers
(Basel). 2023 Feb 9;15(4):1120∟.
doi: 10.3390/cancers15041120∟.
PMID: 36831464∟.
Review. ˍ
*
Kim Y,
Armstrong TS, Gilbert MR, Celiku O.
A
Critical Analysis of Neuro-Oncology Clinical Trials.
Neuro
Oncol. 2023 Feb 9:noad036∟.
doi: 10.1093/neuonc/noad036∟.
PMID: 36757281∟.
Review. ˍ
Makowska M,
Smolarz B, Romanowicz H.
microRNAs
(miRNAs) in Glioblastoma Multiforme (GBM)-Recent Literature
Review.
Int
J Mol Sci. 2023 Feb 9;24(4):3521∟.
doi: 10.3390/ijms24043521∟.
PMID: 36834933∟.
Review. ˍ
*
Schramm MWJ,
Currie S, Lee MT, Livermore LJ, Solanki SP, Mathew RK, Wurdak H,
Lorger M, Twelves C, Short SC, Chakrabarty A, Chumas P.
Do
animal models of brain tumors replicate human peritumoral edema? a
systematic literature search.
J
Neurooncol. 2023 Feb 9∟.
doi: 10.1007/s11060-023-04246-1∟.
PMID: 36757526∟.
Review. ˍ
Hosseinalizadeh
H, Rahmati M, Ebrahimi A, O'Connor RS.
Current
Status and Challenges of Vaccination Therapy for Glioblastoma.
Mol
Cancer Ther. 2023 Feb 10:MCT-22-0503∟.
doi: 10.1158/1535-7163.MCT-22-0503∟.
PMID: 36779991∟.
Review˰ ˍ
Nabavizadeh
A, Barkovich MJ, Mian A, Ngo V, Kazerooni AF, Villanueva-Meyer
JE.
Current
state of pediatric neuro-oncology imaging, challenges and future
directions.
Neoplasia.
2023 Feb 10;37:100886∟.
doi: 10.1016/j.neo.2023.100886∟.
PMID: 36774835∟.
Review. ˍ
Shi Y, Liu C,
Cheng D, Tang L, Qi Z.
Effects
of gross total resection and subtotal resection on survival
outcomes of glioma patients: a meta-analysis.
Biotechnol
Genet Eng Rev. 2023 Feb 10:1-24∟.
doi: 10.1080/02648725.2023.2177034∟.
PMID: 36772792∟.
Meta-analysis˰ ˍ
Xie Y, Hou T,
Liu J, Zhang H, Liu X, Kang R, Tang D.
Autophagy-dependent
ferroptosis as a potential treatment for glioblastoma.
Front
Oncol. 2023 Feb 10;13:1091118∟.
doi: 10.3389/fonc.2023.1091118∟.
PMID: 36845736∟.
Review. ˍ
Young JS,
Al-Adli N, Scotford K, Cha S, Berger MS.
Pseudoprogression
versus true progression in glioblastoma: what neurosurgeons need
to know.
J
Neurosurg. 2023 Feb 10:1-12∟.
doi: 10.3171/2022.12.JNS222173(?). PMID: 36790010∟.
Review˰ ˍ
*
Decraene B,
Vanmechelen M, Clement P, Daisne JF, Vanden Bempt I, Sciot R, Garg
AD, Agostinis P, De Smet F, De Vleeschouwer S.
Cellular
and molecular features related to exceptional therapy response and
extreme long-term survival in glioblastoma.
Cancer
Med. 2023 Feb 12∟.
doi: 10.1002/cam4.5681∟.
PMID: 36776000∟.
Review.
ˍ
Aronica E,
Ciusani E, Coppola A, Costa C, Russo E, Salmaggi A, Perversi F,
Maschio M.
Epilepsy
and brain tumors: Two sides of the same coin.
J
Neurol Sci. 2023 Feb 13;446:120584∟.
doi: 10.1016/j.jns.2023.120584∟.
PMID: 36842341∟.
Review. ˍ
Farrukh S,
Habib S, Rafaqat A, Sarfraz Z, Sarfraz A, Sarfraz M,
Robles-Velasco K, Felix M, Cherrez-Ojeda I.
Emerging
Therapeutic Strategies for Diffuse Intrinsic Pontine Glioma: A
Systematic Review.
Healthcare
(Basel). 2023 Feb 13;11(4):559∟.
doi: 10.3390/healthcare11040559∟.
PMID: 36833093∟.
Review. ˍ
Armitage AE,
Fonkem E.
Supportive
care of neurodegenerative patients.
Front
Oncol. 2023 Feb 14;13:1029938∟.
doi: 10.3389/fonc.2023.1029938∟.
PMID: 36865803∟.
Review. ˍ
Durrani S, Tebha SS, Qamar MA, Nathani KR, Harrison DJ, Aljameey
UA, Jarrah R, Shoushtari A, Bydon M.
Central
neurocytomas: research trends, most cited papers, and
scientometrics analysis to date.
Neurosurg Rev. 2023
Feb 14;46(1):57∟.
doi: 10.1007/s10143-023-01960-2∟.
PMID: 36786867∟.
Bibliometric
analysis˰ ˍ
Lechpammer M,
Mahammedi A, Pomeranz Krummel DA, Sengupta S.
Lessons
learned from evolving frameworks in adult glioblastoma.
Handb
Clin Neurol. 2023 Feb 14;192:131-140∟.
doi: 10.1016/B978-0-323-85538-9.00011-0∟.
PMID: 36796938∟.
Review˰ ˍ
Petković
M, Henis M, Heese O, Relógio A.
Chronotherapy
in Glioblastoma: State of the art and future
perspectives.
EBioMedicine.
2023 Feb 14;89:104470∟.
doi: 10.1016/j.ebiom.2023.104470∟.
PMID: 36796229∟.
Review. ˍ
Singer L, Primdahl D, Kumthekar P.
Neuro-Oncology
in Women: Clinical Considerations.
Neurol
Clin. 2023 Feb 14;41(2):331-342∟.
doi: 10.1016/j.ncl.2022.10.005∟.
PMID: 37030961∟.
Review˰
ˍ
Fares J,
Davis ZB, Rechberger JS, Toll SA, Schwartz JD, Daniels DJ, Miller
JS, Khatua S.
Advances
in NK cell therapy for brain tumors.
NPJ
Precis Oncol. 2023 Feb 15;7(1):17∟.
doi: 10.1038/s41698-023-00356-1∟.
PMID: 36792722∟.
Review. ˍ
Lassman AB,
van den Bent MJ.
What
is a glioblastoma?
Neuro
Oncol. 2023 Feb 15:noad044∟.
doi: 10.1093/neuonc/noad044∟.
PMID: 36789896∟.
Editorial. ˍ